Clinical Trial: Mucosal Impedance and Eosinophilic Esophagitis
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: Mucosal Impedance in Eosinophilic Esophagitis and the Effect of Treatment
Brief Summary:
Do patients with eosinophilic esophagitis have baseline increased esophageal mucosal impedance?
And will treatment that reverses esophageal eosinophilia in patients, correct abnormalities in mucosal impedance?
Detailed Summary:
Sponsor: Mayo Clinic
Current Primary Outcome: Effective treatment is defined by the elimination of esophageal eosinophilia on follow up endoscopic biopsy. [ Time Frame: basesline to one year ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Mayo Clinic
Dates:
Date Received: September 26, 2013
Date Started: September 2013
Date Completion: December 2017
Last Updated: September 12, 2016
Last Verified: September 2016